PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

A novel Ca current blocker promotes angiogenesis and cardiac healing after experimental myocardial infarction in mice.

Mixed / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29890255 ↗2018Reported benefit

A novel Ca current blocker promotes angiogenesis and cardiac healing after experimental myocardial infarction in mice.

MixedIschaemia-reperfusionCardiacC57BL/6Male12 to 24 mg/kg in mice; 50 to 200 microM in zebrafish; 200…Treatment given after myocardial infarction for 14 days

Model: Experimental myocardial infarction

ADTM at 12 to 24 mg/kg for 14 days significantly reduced myocardial infarct size and increased peri-infarct vessel density, and 24 mg/kg raised serum VEGF (P < 0.05). ADTM rescued chemical-induced vessel loss in zebrafish and increased VEGF in A7r5 cells, and at 200 microM inhibited L-type calcium…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.